Advertise on podcast: American Brachytherapy Society (ABS) Podcast

What if prostate cancer is no longer the greatest threat to a man after treatment? Dr. Shalini Moningi joins Dr. Manuj Agarwal to examine cardiovascular outcomes after high-risk prostate cancer treatment. Using long-term brachytherapy data as the starting point, they discuss ADT duration, erectile dysfunction as a vascular clue, smoking, exercise, multidisciplinary risk reduction, and why cancer control should be paired with cardiovascular prevention. Featuring: Shalini Moningi, MD Host: Manuj Agarwal, MD,

The 2026 Judith Stitt Plenary Abstracts represent the premier scientific selections of the 2026 ABS Annual Meeting—rigorous, high‑impact work from across the field. Continue the conversation with our special edition of BrachyBites:Lights, Camera, Precision! Highlighting The Judith Stitt Plenary Abstracts from the 2026 ABS Annual Meeting, featuring the voices behind this year’s leading research.

Featuring: Beth Erickson, MDAkila Viwanathan, MDHost: Matt Harkenrider, MDDr. Beth Erickson and Dr. Akila Viswanathan, both former presidents of the American Brachytherapy Society, recently co-authored a Red Journal editorial entitled “Out from the Shadows and Into the Spotlight:  Making Gynecologic Brachytherapy Available and Sustainable for Patients and Providers."  In this episode of the ABS podcast, they join Dr. Matthew Harkenrider to discuss the evolving complexities of GYN brachytherapy and some strategies on how to be successful and fulfilled in a team-based approach while highlighting the importance of advocacy for this life-saving therapy.  Don't forget the donuts!

Dr. Oliver Sartor, one of the leading voices in advanced prostate cancer and radiopharmaceutical therapy, joins the ABS BrachyBites Podcast to discuss radioligand therapy and its growing impact on the field. We explore patient selection, sequencing, and how radioligands build on the same precision-focused principles that have long defined brachytherapy—offering a look at the future of targeted radiation in prostate cancer.

In this episode of Brachy Bites, Dr. Agarwal interviews Dr. Michael Garcia who breaks down the clinical problem that GammaTile was designed to solve: the vulnerability of the postoperative treatment gap in brain tumor care. From the limitations of standard postoperative SRS to the biology of rapid early recurrence, we explore how immediate, surgically targeted cesium-131 brachytherapy is reshaping local control in brain metastases and glioblastoma. Dr. Garcia discusses patient selection, preoperative planning, workflow, and barriers to adoption. We also unpack the ROADS interim data demonstrating a reduction in recurrence or death versus postoperative SRS. If confirmed, could this redefine standard of care for operable brain metastases? This conversation explores the evidence, the biology, and what comes next for CNS brachytherapy.

To recognize cervical cancer awareness month, Dr. Junzo Chino and Dr. Elizabeth Kidd join Dr. Matthew Harkenrider to discuss their recent manuscript entitled "The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer."  As renowned experts in advanced GYN brachytherapy, Drs. Chino and Kidd share their experiences and guidance for best practices in hybrid IC/IS cervical cancer brachytherapy.  Their approaches are practical and achievable so that the evolving GYN brachytherapy program can thrive.

Dr. Parag Sanghvi, Professor of Radiation Oncology from UC San Diego, joins Dr. Matt Harkenrider on this episode of the ABS podcast to discuss all things skin brachytherapy. As a renowned brachytherapist, Dr Sanghvi shares his wealth of experience in an approachable way. From starting a new program to advanced skin applications, Dr. Sanghvi covers it all.

Dr. Grgur Miric joins the ABS Podcast to reflect on the evolution of prostate brachytherapy, the lessons of high-volume practice, and how he combined cancer care with community impact through basketball and mentorship.

In our inaugural International Spotlight, Dr. Hathal Haddad of University Hospital Tübingen discusses advances in prostate brachytherapy — from prostate artery embolization (PAE) to AI-assisted workflows. A leader in interventional radiotherapy, he shares how his team is shaping the future of precision care in Germany and beyond.

Dr. Manuj Agarwal joins the ABS Podcast for Prostate Cancer Awareness Month to discuss life after prostate cancer treatment, minimizing ADT side effects, and optimizing long-term health. He shares insights from thousands of cases and his work in integrative oncology and longevity medicine.

As presented on June 20, 2025 at the ABS Annual Conference Live from the ABS,  Dr. Cate Yashar and Dr. Mitch Kamrava as brachytherapy thought leaders join Dr. Matt Harkenrider for a lively discussion spanning a range of topics about the future of brachytherapy.  We discuss how to work at an institutional level to develop and advocate for a brachytherapy program and then how, we as a specialty, need to teach, research, and innovate for brachytherapy of the future.  The future of brachytherapy is bright!

Dr. Elizabeth Kidd and Dr. Santino Butler are co-primary authors of the recent manuscript entitled “Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American Brachytherapy Society” that was recenlty published in the Brachytherapy Journal.  In this episode, we discuss how the landscape of cervical cancer brachytherapy has evolved in the last decade including some provocative thoughts where we are heading in the coming years.  Drs Kidd and Butler also go beyond just practice patterns and give some insights into best practices in the management of cervical cancer patients.

In this episode of the American Brachytherapy Society podcast, we sit down with Michael Krachon, President of Theragenics International, and Lory Bradley, a seasoned industry expert with decades of experience in prostate brachytherapy. Together, they reflect on the evolution of the field—from the early days of seed implants to modern-day innovations and challenges. Michael shares insights from his long career in the prostate seed business, highlighting the pivotal role of physician partnerships, the rise and fall of brachytherapy utilization, and the path forward for restoring its prominence in prostate cancer care. Lory offers additional perspective on the clinical and logistical advancements that have shaped practice patterns over time. Whether you're a clinician, trainee, or industry partner, this episode provides valuable historical context, practical wisdom, and a hopeful outlook for the future of LDR brachytherapy.

On this episode of the ABS Podcast, Dr. Gita Suneja and Dr. Cristina DeCesaris join Dr. Harkenrider to discuss the quality of life and financial analyses of the SAVE trial. The SAVE trial randomized patients to a 2 fraction regimen vs a standard of care regimen of VBT with an emphasis on pragmatic design and inclusive enrollment to measure patient centered outcomes.  Join our lively discussion on trial design and creating treatment options that matter for patients!

In this episode of the American Brachytherapy Society podcast, Dr. Alexandra Stewart, Consultant Clinical Oncologist at the Royal Surrey, discusses the evolving role of rectal brachytherapy in non-operative management of rectal cancer. Drawing from her expertise and international experience, Dr. Stewart explores key findings from the OPERA trial, patient selection criteria, dosing strategies, and the latest advancements in contact X-ray brachytherapy (CXB) techniques. She also highlights the impact of treatment protocols on clinical outcomes and future directions, including insights into the TRESOR trial. Tune in for an in-depth conversation on how brachytherapy is shaping the future of rectal cancer care.